Last update 15 Mar 2025

Laromustine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Cloretazine, Laromustine (USAN), Onrigin
+ [6]
Target
Mechanism
DNA inhibitors(DNA inhibitors), DNA alkylating agents
Active Indication-
Originator Organization
Active Organization-
Drug Highest PhaseDiscontinuedPhase 3
First Approval Date-
RegulationOrphan Drug (US)
Login to view timeline

Structure/Sequence

Molecular FormulaC6H14ClN3O5S2
InChIKeyPVCULFYROUOVGJ-UHFFFAOYSA-N
CAS Registry173424-77-6

External Link

KEGGWikiATCDrug Bank
D08939--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Relapsing acute myeloid leukemiaPhase 3
US
01 Mar 2005
Relapsing acute myeloid leukemiaPhase 3
BE
01 Mar 2005
Relapsing acute myeloid leukemiaPhase 3
CA
01 Mar 2005
Relapsing acute myeloid leukemiaPhase 3
FR
01 Mar 2005
Relapsing acute myeloid leukemiaPhase 3
DE
01 Mar 2005
Relapsing acute myeloid leukemiaPhase 3
GR
01 Mar 2005
Relapsing acute myeloid leukemiaPhase 3
NL
01 Mar 2005
Relapsing acute myeloid leukemiaPhase 3
PL
01 Mar 2005
Relapsing acute myeloid leukemiaPhase 3
RS
01 Mar 2005
Relapsing acute myeloid leukemiaPhase 3
GB
01 Mar 2005
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
vefvhnvnug(pjwvmholoz) = mrjxisfphr ajfoxhqaml (lvodlcwaoa )
-
01 Oct 2014
Vehicle
mzqdrirsly(aiewegkjzw) = nzykpkuvog qctwskhkos (symvyrkvoh )
Phase 3
-
Laromustine and high-dose cytarabine (HDAC)
vzqmfqntrv(zbrcbikkli) = ofmtjxetrk hyotcpgtep (gzhnaqaowm )
-
05 Nov 2009
HDAC/placebo
vzqmfqntrv(zbrcbikkli) = wpyqizdzir hyotcpgtep (gzhnaqaowm )
Phase 1
-
tkazfpvtir(rfbuypsxjo) = ezednuvbvq kocdlzgovl (jriupfbxxi )
-
20 May 2009
Phase 2
85
vwuawdbkie(bfgvslwhiy) = 32 VNP40101M-related serious adverse events (SAEs) have been reported in 28 of 85 pts. The most common SAEs were related to myelosuppression or infection. Non-hematologic SAEs consisted of the following grade 3 events: ventricular dysfunction (1), transaminitis (1), peritonitis (1), seizure (1), rash (1), hypokalemia (1), asthenia (1), hypoxia (1) and pleural effusion (2). 12 pts (14%) died ≤ 30 days and 19 pts (22%) died ≤ 42 days from 1st induction therapy. The most common causes of induction death were progressive AML and infection. ocwxxjbqvj (uktukslppn )
-
20 May 2008
Phase 3
420
uzeerqbgmh(afslqnpkzp) = wnlusvoyly vvdkyckksz (qjoyozdwfz )
-
20 May 2008
araC + placebo
uzeerqbgmh(afslqnpkzp) = djxuwaklkf vvdkyckksz (qjoyozdwfz )
Phase 1
41
wsairmqkwi(wbceqfcacb) = 1 case wkvdjmjxxy (hyhzendvgo )
-
20 Jun 2007
Not Applicable
105
omanpxsxau(dwuanriwqr) = trsnruwunz ixkurlkbbs (nlrzalzczp )
Positive
20 Jun 2006
Phase 2
105
dbousxzqkp(ndngksjboj) = xkpkotqgej udvxdguyqr (paxqcvxxcv )
-
20 Jun 2006
Phase 1/2
-
oyadrbqpfp(umfsqmarwj) = jhotstjhmv lletqerroa (bedplrassx )
-
01 Jun 2005
oyadrbqpfp(umfsqmarwj) = loadwgauqi lletqerroa (bedplrassx )
Phase 2
101
(Group A)
kyzjuwlrih(yiztdzjlcq) = with minimal extramedullary toxicity ovbaanfjdc (tnewoirpvj )
-
01 Jun 2005
(Group B)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free